IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NEA Management Company, LLC

Q4 2025 Holdings

Filed 2026-02-17 | 27 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celcuity Inc.(CELC)COM15102K100$352.6M3,535,56118.0%
Rhythm Pharmaceuticals, Inc.(RYTM)COM76243J105$311.5M2,909,95615.9%
Arcellx, Inc.(ACLX)COMMON STOCK03940C100$198.6M3,045,26210.1%
Trevi Therapeutics, Inc.(TRVI)COM89532M101$165.5M13,222,2288.4%
Savara, Inc.(SVRA)COM805111101$147.6M24,471,2647.5%
Zenas BioPharma, Inc.(ZBIO)COM98937L105$127.9M3,523,2196.5%
Monte Rosa Therapeutics, Inc.(GLUE)COM61225M102$120.6M7,692,2986.2%
MBX Biosciences, Inc.(MBX)COM55287L101$114.0M3,614,4865.8%
Coursera, Inc.(COUR)COM22266M104$94.7M12,867,7694.8%
Aurinia Pharmaceuticals, Inc.(AUPH)COM05156V102$63.3M3,969,8343.2%
Gossamer Bio, Inc.(GOSS)COM38341P102$56.1M18,093,0342.9%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$55.5M1,058,5702.8%
Oric Pharmaceuticals, Inc.(ORIC)COM68622P109$33.7M4,118,6211.7%
Phathom Pharmaceauticals, Inc.(PHAT)COM71722W107$32.5M1,960,1691.7%
CVRx, Inc.(CVRX)COM126638105$14.4M2,026,0830.7%
X4 Pharmaceuticals, Inc.(ASNSUSD)COM98420X103$12.9M3,233,7430.7%
Champions Oncology, Inc.(CSBR)COM NEW15870P307$11.8M1,713,7200.6%
Black Diamond Therapeutics, Inc.(BDTX)COM09203E105$10.8M4,448,7570.6%
Korro Bio, Inc.(KRRO)COM500946108$8.7M1,090,7930.4%
Inventiva SA(IVA)ADS46124U107$6.8M1,462,5860.3%
Nkarta, Inc.(NKTX)COM65487U108$6.6M3,568,7810.3%
Senti Biosciences, Inc.(SNTI)COM NEW81726A209$3.9M3,775,6150.2%
LeonaBio, Inc.(LONA)COM04746L203$3.5M464,3980.2%
Synlogic, Inc.(SYBX)COM NEW87166L209$3.3M2,922,7720.2%
Marker Therapeutics, Inc.(MRKR)COM NEW57055L206$2.4M1,625,6780.1%
OnKure Therapeutics, Inc.(OKUR)COM CL A68277Q105$1.4M478,5480.1%
ImageneBio, Inc.(IMA)COM45175G207$345.0K50,0050.0%